<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-30T23:08:17+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【2692】【2020金研奖】周彩存教授：有了靶向治疗，有了免疫治疗，肺癌逐步会成为慢性病</title>
    <updated>2020-12-30T18:55:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/V8rqIazeHGODPsqfuGJR8A</id>
    <link href="https://mp.weixin.qq.com/s/V8rqIazeHGODPsqfuGJR8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>HOW WE TREAT GIST大型网络云会议暨2020年GIST年终盘点邀请函</title>
    <updated>2020-12-30T18:55:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/4veia_vHFoevbyd4WPZHQg</id>
    <link href="https://mp.weixin.qq.com/s/4veia_vHFoevbyd4WPZHQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“GIST 新时空”专栏 | 赵雪峰教授解析：使用伊马替尼之外的多靶点激酶抑制剂用于一线治疗晚期胃肠间质瘤(GIST)患者的结局</title>
    <updated>2020-12-30T18:55:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/azc4EYl5LQ61r8cz_DruFA</id>
    <link href="https://mp.weixin.qq.com/s/azc4EYl5LQ61r8cz_DruFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离闷死病毒，学习看活研究” | 【10】探索OFS跌宕起伏的离奇经历之 INTERGROUP研究解读</title>
    <updated>2020-12-30T18:55:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/yj8AA1ckZAQS_CWd74O_ng</id>
    <link href="https://mp.weixin.qq.com/s/yj8AA1ckZAQS_CWd74O_ng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2691】硕果累累，全球首款RANKL抑制剂地舒单抗，近日成功进入国家医保！</title>
    <updated>2020-12-29T19:25:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/50h-g5Dy71hyfqEMnGLZsQ</id>
    <link href="https://mp.weixin.qq.com/s/50h-g5Dy71hyfqEMnGLZsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>王洁教授团队发现新型肺腺癌免疫治疗疗效预测生物标志物</title>
    <updated>2020-12-29T19:25:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/koZR7Tox9OWJ_3yVxBPHPw</id>
    <link href="https://mp.weixin.qq.com/s/koZR7Tox9OWJ_3yVxBPHPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CDK4/6i学院】靶向CDK4/6抑制剂一线治疗HR+原发耐药内脏转移乳腺癌患者，假性进展后达到PR，且PFS已超过20个月</title>
    <updated>2020-12-29T19:25:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/4WcUNSx_6bPD1MlsfZiq4w</id>
    <link href="https://mp.weixin.qq.com/s/4WcUNSx_6bPD1MlsfZiq4w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>风骨多美，声势加素丨2020 CSCO《经典型骨肉瘤诊疗指南》巡讲·三亚站隆重落幕！</title>
    <updated>2020-12-29T19:25:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/xNtm8-9ygkHdYtGOa7YRIQ</id>
    <link href="https://mp.weixin.qq.com/s/xNtm8-9ygkHdYtGOa7YRIQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离闷死病毒，学习看活研究”| 【9】探索OFS跌宕起伏的离奇经历之 ASTRRA研究解读</title>
    <updated>2020-12-29T19:25:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/VTnOMdedy7cD7g3KtFmdZA</id>
    <link href="https://mp.weixin.qq.com/s/VTnOMdedy7cD7g3KtFmdZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>为什么女性一定要做乳腺癌筛查</title>
    <updated>2020-12-29T19:25:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/zfkrJkpJ8f9B1lywNc8Jfg</id>
    <link href="https://mp.weixin.qq.com/s/zfkrJkpJ8f9B1lywNc8Jfg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2690】不负韶华，乘风破浪——2020年安罗替尼学术大盘点</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/PRY4NiIuF9My3RBryHrpRg</id>
    <link href="https://mp.weixin.qq.com/s/PRY4NiIuF9My3RBryHrpRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>我国首个自主研发上市的抗PD-1单抗 特瑞普利单抗注射液（拓益®）纳入国家医保目录</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/TPRP6nXcihlLJ-6A1fyrDw</id>
    <link href="https://mp.weixin.qq.com/s/TPRP6nXcihlLJ-6A1fyrDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“买4个疗程保终身”，医保之外，慈善赠药惠及更多肿瘤患者</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/U4DEQhUB9BYw0iiUfTqQxA</id>
    <link href="https://mp.weixin.qq.com/s/U4DEQhUB9BYw0iiUfTqQxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【完美收官】首届肿瘤诊疗黑科技大会—暨肿瘤诊疗黑科技年度TOP 20正式揭晓！</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/tgmkWMR8YyIgZzdvMPOb9g</id>
    <link href="https://mp.weixin.qq.com/s/tgmkWMR8YyIgZzdvMPOb9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020首届中国癌症防治年度大会在京召开，首批“人民好医生·金山茶花计划”获奖名单公布</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/1n6k0mUG8nziSFazfVZx8A</id>
    <link href="https://mp.weixin.qq.com/s/1n6k0mUG8nziSFazfVZx8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离闷死病毒，学习看活研究” | 【8】探索OFS跌宕起伏的离奇经历之 SOFT-TEXT联合分析</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/kgc6l-wL3VpWitNisc4fcg</id>
    <link href="https://mp.weixin.qq.com/s/kgc6l-wL3VpWitNisc4fcg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】新增17种抗肿瘤药，119种谈判成功，2020年国家医保药品目录正式公布</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/PP97FsJW4cN89Yz2XGTSLA</id>
    <link href="https://mp.weixin.qq.com/s/PP97FsJW4cN89Yz2XGTSLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【预告】“泌尿肿瘤免疫治疗系列沙龙”学术会议来袭，精彩不容错过！</title>
    <updated>2020-12-28T20:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/TH4cbjStpzAcW0yh5H4wSQ</id>
    <link href="https://mp.weixin.qq.com/s/TH4cbjStpzAcW0yh5H4wSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2689】「重磅揭晓」2020年度TOP20肿瘤诊疗黑科技颁奖，于明晚18:30公布</title>
    <updated>2020-12-27T19:38:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/o0RmWBuevQby-fT1mSJfDw</id>
    <link href="https://mp.weixin.qq.com/s/o0RmWBuevQby-fT1mSJfDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Adapting the EXTREME Regimen</title>
    <updated>2020-12-27T19:38:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/tU3ttkBOEFLmMHlQnfWHTw</id>
    <link href="https://mp.weixin.qq.com/s/tU3ttkBOEFLmMHlQnfWHTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>